📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Humoral and Cellular Immunity to SARS-CoV-2 Vaccination in Cancer Patients: Completed Prospective Observational Study Using BNT162b2 mRNA Vaccine (2021)

First Author: McKenzie D

Attributed to: Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3919693

Publication URI: http://dx.doi.org/10.2139/ssrn.3919693

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal